# Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury

> **NCT01223001** · PHASE2 · TERMINATED · sponsor: **Rehabilitation Hospital of Indiana** · enrollment: 8 (actual)

## Conditions studied

- Traumatic Brain Injury
- Depression

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Sugar pill

## Key facts

- **NCT ID:** NCT01223001
- **Lead sponsor:** Rehabilitation Hospital of Indiana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1996-09
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Most potential subjects had already been prescribed Cymbalta.
- **Last updated:** 2014-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01223001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01223001, "Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01223001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*